Inhibitors of the Janus Kinases: A New Oral Treatment Option for Ulcerative Colitis.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Gastroenterology"
DOI: 10.1097/mcg.0000000000001404
Abstract: To the Editor: As the Medical Strategy Head Gastroenterology and Global Medical Lead for Xeljanz ulcerative colitis (UC), Inflammation and Immunology Medical Affairs, at Pfizer Inc., I read with great interest the article by Antonelli… read more here.
Keywords: gastroenterology; ulcerative colitis; janus kinases; inhibitors janus ... See more keywords